Overview Financials News + Filings
|
|
QLY Biotech Group Corp.
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Feb-28-23 | Nov-30-22 | Aug-31-22 | May-31-22 | Feb-28-22 | Nov-30-21 | Aug-31-21 | May-31-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | | | | | | | 100.0% | |
| Cost of goods sold | | | | | | | 35.0% | |
| Gross profit | | | | | | | 65.0% | |
| General and administrative | | | | | | | 50.1% | |
| Depreciation | | | | | | | -2.1% | |
| EBITA | | | | | | | 54.9% | |
| Amortization of intangibles | | | | | | | -30.0% | |
| EBIT | | | | | | | 84.9% | |
| Pre-tax income | | | | | | | 14.9% | |
| Income taxes | | | | | | | 0.0% | |
| Net income | | | | | | | 14.9% | |
|